Study: Infliximab-related weight gain still a mystery

10/17/2007 | MedPage Today (free registration)

At the ACG meeting this week, a University of North Carolina at Chapel Hill researcher reported that scientists know infliximab treatment for Crohn's disease leads to significant weight gain, but that they still aren't sure why. The researcher also noted that some weight gain in Crohn's patients is desirable as these patients tend to be undernourished, but that the 60- to 75-pound gain in some patients brings added concerns about the health risks of obesity.

View Full Article in:

MedPage Today (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Legal Counsel
Alcon
Fort Worth, TX
Director, Senior Legal Counsel
Alcon
Fort Worth, TX
Corporate Counsel - Healthcare Law Group
Genentech
South San Francisco, CA
Manager/Senior Manager, Health Services Analytics
Avalere Health
Washington, DC
Manager/Senior Manager, Health Economist
Avalere Health
Washington, DC